| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0004 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0006 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.37 | 0.001 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.094 | 0.002 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | -0.12 | 0.004 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | 0.096 | 0.005 |